IQVIA
Biosimilar Uptake Remains Variable, Posing Challenges to the Market
Four key dynamics—coverage and access, average sales price, provider net cost recovery, and patient cost ...
OCTOBER 9, 2024

Obesity Rx ‘Gold Rush’ Among Market Trends To Watch: Doug Long
The pharmaceutical marketplace may be a hard thing to predict, but there is at least one event that attendees at ...
MAY 22, 2024

IQVIA: Innovation and COVID-19 Vaccines Will Drive Global Medicine Spending Through 2027
Medicine spending through the next five years will be driven by global COVID-19 vaccinations and new innovations in ...
FEBRUARY 3, 2023

IQVIA Report: Specialty Drugs Stayed Strong in 2022
Specialty drugs currently account for 50% of nondiscounted drug spending, with specialty growth continuing to ...
NOVEMBER 12, 2022

2017 in Review: Fighting for the Specialty Market & Pt Journey
Every year a 2012 statement made by Phil Hagerman, RPh, the CEO at Diplomat, becomes a little truer: Specialty is ...
DECEMBER 30, 2017
